United Imaging Medical (688271) announced on the evening of March 14 that shareholders Zhongke State Street and Beiyuan Investment plan to reduce their holdings by a total of 29,086,400 shares, accounting for 3.53% of the company's total share capital, due to their own capital needs. The transferor promises that the shares held by it have been lifted, the ownership is clear, and there is no situation where the shareholding cannot be reduced. The minimum transfer price shall not be less than 70% of the average stock trading price in the 20 trading days prior to the date of sending the subscription invitation, which will be organized and implemented by China International Capital Corporation Limited. The transferee must be an institutional investor with appropriate pricing power and risk tolerance.

According to the data, United Imaging Healthcare's main business is to provide global customers with high-performance medical imaging equipment, radiotherapy products, life science instruments and medical digital and intelligent solutions. The company was listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange in August 2022.

Reading Finance noticed that Zhongke State Street and Beiyuan Investment were its shareholders before the listing of United Imaging Medical and participated in its A1 round of investment.

Previously, the above two shareholders had reduced their holdings. On May 24, 2024, Zhongke State Street and Beiyuan Investment also reduced their holdings by a total of 9 million shares and cashed out more than 1 billion yuan through inquiry and transfer.

In addition, on July 22, 2024, United Imaging Medical's employee shareholding platforms Ningbo Yingju, Ningbo Yingli, Ningbo Yingjian, Ningbo Yingkang, and Shanghai Yingdong reduced their holdings by a total of 7,471,530 shares through centralized bidding and block trading, cashing out 894 million yuan.

On February 28, United Imaging Medical released its 2024 performance report, saying that the company achieved operating income of 10.3 billion yuan, a year-on-year decrease of 9.73%; The net profit attributable to the parent company was 1.262 billion yuan, a year-on-year decrease of 36.08%.

Regarding the decline in revenue and net profit, United Imaging Medical explained that due to the impact of the domestic equipment renewal policy on the market, the industry scale has shrunk significantly compared with the same period last year, and the domestic revenue has decreased compared with the same period last year; Secondly, some of the company's high-end new products have a long market introduction period, and it will take time to contribute to the performance; In addition, the company continued to increase R&D investment and business expansion, and R&D expenses and sales expenses increased year-on-year.

It is worth mentioning that this is the first time in the past six years that United Imaging Medical's net profit attributable to the parent company has declined.

In the secondary market, United Imaging Medical rose 0.67% on the 14th to close at 130.85 yuan per share. Compared with the high level of the company just after listing, the company's stock price has fallen by about 40%.

Source: Reading and Entrepreneurship